The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis

Argelia Medeiros-Domingo, Zahurul A Bhuiyan, David J Tester, Nynke Hofman, Hennie Bikker, J Peter van Tintelen, Marcel M A M Mannens, Arthur A M Wilde, Michael J Ackerman

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

OBJECTIVES: This study was undertaken to determine the spectrum and prevalence of mutations in the RYR2-encoded cardiac ryanodine receptor in cases with exertional syncope and normal corrected QT interval (QTc).

BACKGROUND: Mutations in RYR2 cause type 1 catecholaminergic polymorphic ventricular tachycardia (CPVT1), a cardiac channelopathy with increased propensity for lethal ventricular dysrhythmias. Most RYR2 mutational analyses target 3 canonical domains encoded by <40% of the translated exons. The extent of CPVT1-associated mutations localizing outside of these domains remains unknown as RYR2 has not been examined comprehensively in most patient cohorts.

METHODS: Mutational analysis of all RYR2 exons was performed using polymerase chain reaction, high-performance liquid chromatography, and deoxyribonucleic acid sequencing on 155 unrelated patients (49% females, 96% Caucasian, age at diagnosis 20 +/- 15 years, mean QTc 428 +/- 29 ms), with either clinical diagnosis of CPVT (n = 110) or an initial diagnosis of exercise-induced long QT syndrome but with QTc <480 ms and a subsequent negative long QT syndrome genetic test (n = 45).

RESULTS: Sixty-three (34 novel) possible CPVT1-associated mutations, absent in 400 reference alleles, were detected in 73 unrelated patients (47%). Thirteen new mutation-containing exons were identified. Two-thirds of the CPVT1-positive patients had mutations that localized to 1 of 16 exons.

CONCLUSIONS: Possible CPVT1 mutations in RYR2 were identified in nearly one-half of this cohort; 45 of the 105 translated exons are now known to host possible mutations. Considering that approximately 65% of CPVT1-positive cases would be discovered by selective analysis of 16 exons, a tiered targeting strategy for CPVT genetic testing should be considered.

Original languageEnglish
Pages (from-to)2065-2074
Number of pages10
JournalJournal of the American College of Cardiology
Volume54
Issue number22
DOIs
Publication statusPublished - 24 Nov 2009
Externally publishedYes

Keywords

  • Adult
  • Calcium Channels/genetics
  • Catecholamines/metabolism
  • DNA Mutational Analysis
  • Death, Sudden, Cardiac/etiology
  • Exercise/physiology
  • Exercise Test
  • Female
  • Genetic Predisposition to Disease/genetics
  • Genotype
  • Humans
  • Long QT Syndrome/genetics
  • Male
  • Mosaicism
  • Open Reading Frames/genetics
  • Ryanodine Receptor Calcium Release Channel/genetics
  • Syncope/genetics
  • Tachycardia, Ventricular/genetics
  • Young Adult

Fingerprint

Dive into the research topics of 'The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis'. Together they form a unique fingerprint.

Cite this